These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18287313)

  • 1. Prevalence of Streptococcus invasive locus (sil) and its relationship with macrolide resistance among group A Streptococcus strains.
    Billal DS; Hotomi M; Shimada J; Fujihara K; Ubukata K; Sugita R; Yamanaka N
    J Clin Microbiol; 2008 Apr; 46(4):1563-4. PubMed ID: 18287313
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of group A streptococcal emm types with virulence traits and macrolide-resistance genes is independent of the source of isolation.
    Creti R; Gherardi G; Imperi M; von Hunolstein C; Baldassarri L; Pataracchia M; Alfarone G; Cardona F; Dicuonzo G; Orefici G
    J Med Microbiol; 2005 Oct; 54(Pt 10):913-917. PubMed ID: 16157543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrolide-resistant Streptococcus pyogenes in Central Greece: prevalence; mechanism and molecular identification.
    Malli E; Tatsidou E; Damani A; Pantelidi K; Petinaki E; Skoulakis C; Drougka E; Spiliopoulou I
    Int J Antimicrob Agents; 2010 Jun; 35(6):614-5. PubMed ID: 20206477
    [No Abstract]   [Full Text] [Related]  

  • 4. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary.
    Gattringer R; Sauermann R; Lagler H; Stich K; Buxbaum A; Graninger W; Georgopoulos A
    Int J Antimicrob Agents; 2004 Sep; 24(3):290-3. PubMed ID: 15325435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of macrolide resistance mechanisms in Bulgarian clinical isolates of Streptococcus pyogenes during the years of 2013-2016.
    Muhtarova AA; Gergova RT; Mitov IG
    J Glob Antimicrob Resist; 2017 Sep; 10():238-242. PubMed ID: 28735056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of fibronectin-binding protein genes (prtF1 and prtF2) and streptococcal pyrogenic exotoxin genes (spe) among Streptococcus pyogenes in Japan.
    Hotomi M; Billal DS; Togawa A; Ikeda Y; Takei S; Kono M; Ogami M; Ubukata K; Sugita R; Fujihara K; Yamanaka N
    J Infect Chemother; 2009 Dec; 15(6):367-73. PubMed ID: 20012726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial drug use and macrolide-resistant Streptococcus pyogenes, Belgium.
    Van Heirstraeten L; Coenen S; Lammens C; Hens N; Goossens H; Malhotra-Kumar S
    Emerg Infect Dis; 2012 Sep; 18(9):1515-8. PubMed ID: 22932671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of macrolide-resistant Streptococcus pyogenes strains in French children.
    Bingen E; Bidet P; Mihaila-Amrouche L; Doit C; Forcet S; Brahimi N; Bouvet A; Cohen R
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3559-62. PubMed ID: 15328126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmid-Borne erm(T) from invasive, macrolide-resistant Streptococcus pyogenes strains.
    Woodbury RL; Klammer KA; Xiong Y; Bailiff T; Glennen A; Bartkus JM; Lynfield R; Van Beneden C; Beall BW;
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1140-3. PubMed ID: 18180360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USA.
    Green MD; Beall B; Marcon MJ; Allen CH; Bradley JS; Dashefsky B; Gilsdorf JR; Schutze GE; Smith C; Walter EB; Martin JM; Edwards KM; Barbadora KA; Wald ER
    J Antimicrob Chemother; 2006 Jun; 57(6):1240-3. PubMed ID: 16556634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrolide- and telithromycin-resistant Streptococcus pyogenes, Belgium, 1999-2003.
    Malhotra-Kumar S; Lammens C; Chapelle S; Wijdooghe M; Piessens J; Van Herck K; Goossens H
    Emerg Infect Dis; 2005 Jun; 11(6):939-42. PubMed ID: 15963292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of antimicrobial susceptibility of clinical isolates of Streptococcus pyogenes in Japan: report of a countrywide surveillance study.
    Hotomi M; Billal DS; Shimada J; Yamauchi K; Fujihara K; Yamanaka N;
    J Infect Chemother; 2005 Feb; 11(1):48-51. PubMed ID: 15729489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid inversion of the prevalences of macrolide resistance phenotypes paralleled by a diversification of T and emm types among Streptococcus pyogenes in Portugal.
    Silva-Costa C; Ramirez M; Melo-Cristino J;
    Antimicrob Agents Chemother; 2005 May; 49(5):2109-11. PubMed ID: 15855540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of macrolide resistance in Streptococcus pyogenes collected in Serbia.
    Pavlovic L; Grego E; Sipetic-Grujicic S
    Jpn J Infect Dis; 2010 Jul; 63(4):275-6. PubMed ID: 20657068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of macrolide and fluoroquinolone resistance with molecular typing in Streptococcus pyogenes from invasive infections, 2010-2012.
    Wajima T; Morozumi M; Chiba N; Shouji M; Iwata S; Sakata H; Ubukata K
    Int J Antimicrob Agents; 2013 Nov; 42(5):447-9. PubMed ID: 23988719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of macrolide efflux pump mef subclasses detected in clinical isolates of Streptococcus pyogenes isolated between 1999 and 2005.
    Blackman Northwood J; Del Grosso M; Cossins LR; Coley MD; Creti R; Pantosti A; Farrell DJ
    Antimicrob Agents Chemother; 2009 May; 53(5):1921-5. PubMed ID: 19258262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predominant role of msr(D) over mef(A) in macrolide resistance in Streptococcus pyogenes.
    Zhang Y; Tatsuno I; Okada R; Hata N; Matsumoto M; Isaka M; Isobe KI; Hasegawa T
    Microbiology (Reading); 2016 Jan; 162(1):46-52. PubMed ID: 26531240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and characterization of macrolide resistance in clinical isolates of Streptococcus pneumoniae and Streptococcus pyogenes from North America.
    Hoban DJ
    J Chemother; 2002 Jul; 14 Suppl 3():25-30. PubMed ID: 12418558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mef(A), mef(E) and a new mef allele in macrolide-resistant Streptococcus spp. isolates from Norway.
    Sangvik M; Littauer P; Simonsen GS; Sundsfjord A; Dahl KH
    J Antimicrob Chemother; 2005 Nov; 56(5):841-6. PubMed ID: 16172106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Characteristics of Erythromycin-Resistant Streptococcus pyogenes Strains Isolated from Children Patients in Tunis, Tunisia.
    Ksia S; Smaoui H; Hraoui M; Bouafsoun A; Boutiba-Ben Boubaker I; Kechrid A
    Microb Drug Resist; 2017 Jul; 23(5):633-639. PubMed ID: 27991848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.